William King - Dec 31, 2022 Form 5 Insider Report for DANAHER CORP /DE/ (DHR)

Role
SVP, Strategic Development
Signature
/s/ James F. O'Reilly, attorney-in-fact for William King
Stock symbol
DHR
Transactions as of
Dec 31, 2022
Transactions value $
$8,492
Form type
5
Date filed
2/2/2023, 04:13 PM
Previous filing
Oct 31, 2022
Next filing
Jan 30, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DHR Danaher Deferred Compensation Programs - Danaher Stock Fund Award $3.82K +13.6 +0.07% $281.11 18.7K Jan 28, 2022 Common Stock 13.6 $0.00 Direct F1, F2, F3
transaction DHR Danaher Deferred Compensation Programs - Danaher Stock Fund Award $4.67K +18.6 +0.1% $251.13 18.7K Apr 29, 2022 Common Stock 18.6 $0.00 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents notional dividend accruals on phantom shares in the Danaher stock fund under one or more of the plans that form part of Danaher's deferred compensation program. The number of phantom shares accrued as a result of such notional dividend accruals is based on the closing price of Danaher common stock as reported on the NYSE on the date such dividend accruals are credited to the fund, which is the price shown in Table II, Column 8 above. Beginning in the third quarter of 2022, the Danaher reporting persons began reporting these quarterly notional dividend accruals on a current basis, which is why this Form 5 only reports the accruals that occurred in the first and second quarters of 2022.
F2 The notional shares convert on a one-for-one basis.
F3 The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission.